India’s AINU to see growth due to AHH stake

GlobalData said the strategic move allows AINU to expand its presence.

Analytics firm, GlobalData, said Asia Healthcare Holdings’ (AHH) strategic move to acquire a majority stake in India's Asian Institute of Nephrology and Urology (AINU) will help expand AHH’s fourth speciality.

This allows AHH to establish “itself as the premier and sole single-speciality healthcare delivery platform in both India and the larger Asian subcontinent.”

The investment presents an “enticing growth prospect for AINU, enabling it to expand its presence in both metropolitan areas and tier-2 cities within the country.”

AINU has diagnostics and care for a range of nephrological and urological conditions, encompassing stone disease management, cancer treatments, acute, chronic, and end-stage renal diseases. 

As this happens, India’s nephrology and urology devices market will grow at 4% CAGR through 2030.

“The rising prevalence of non-communicable diseases such as diabetes and hypertension, along with other risk factors, has led to an increasing burden of kidney and urinary tract-related conditions in India,” read the statement.